Trinity Biotech PLC (TRIB)
0.641
-0.03
(-3.97%)
USD |
NASDAQ |
Mar 28, 16:00
0.645
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Max Drawdown (5Y): 97.80% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Amarin Corp PLC | 98.07% |
| DBV Technologies SA | 98.19% |
| Cellectis SA | 97.08% |
| Akari Therapeutics PLC | 98.88% |
| Biodexa Pharmaceuticals PLC | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -56.36 |
| Beta (5Y) | 1.201 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 82.26% |
| Historical Sharpe Ratio (5Y) | -0.4762 |
| Historical Sortino (5Y) | -1.048 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.07% |